These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 22249234)
21. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines. Stewart WC; Konstas AG; Nelson LA; Kruft B Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886 [TBL] [Abstract][Full Text] [Related]
22. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure. Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465 [TBL] [Abstract][Full Text] [Related]
23. A 3-month safety and efficacy study of travoprost 0.004% ophthalmic solution compared with timolol in pediatric patients with glaucoma or ocular hypertension. Dixon ER; Landry T; Venkataraman S; Gustafson N; Salem C; Bradfield Y; Aljasim LA; Feldman R J AAPOS; 2017 Oct; 21(5):370-374.e1. PubMed ID: 28887006 [TBL] [Abstract][Full Text] [Related]
24. Latanoprost : an update of its use in glaucoma and ocular hypertension. Perry CM; McGavin JK; Culy CR; Ibbotson T Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627 [TBL] [Abstract][Full Text] [Related]
25. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy. Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406 [TBL] [Abstract][Full Text] [Related]
26. Fixed-combination brimonidine/timolol as adjunctive therapy to a prostaglandin analog: a 3-month, open-label, replacement study in glaucoma patients. Nguyen QH; Earl M J Ocul Pharmacol Ther; 2009 Dec; 25(6):541-4. PubMed ID: 20028261 [TBL] [Abstract][Full Text] [Related]
27. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension. Easthope SE; Perry CM Drugs Aging; 2002; 19(3):231-48. PubMed ID: 12027782 [TBL] [Abstract][Full Text] [Related]
28. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448 [TBL] [Abstract][Full Text] [Related]
29. Comparison of 24-hour intraocular pressure reduction obtained with brinzolamide/timolol or brimonidine/timolol fixed-combination adjunctive to travoprost therapy. Konstas AG; Holló G; Haidich AB; Mikropoulos DG; Giannopoulos T; Voudouragkaki IC; Paschalinou E; Konidaris V; Samples JR J Ocul Pharmacol Ther; 2013 Sep; 29(7):652-7. PubMed ID: 23550916 [TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of medical intervention for normal tension glaucoma. Cheng JW; Cai JP; Wei RL Ophthalmology; 2009 Jul; 116(7):1243-9. PubMed ID: 19450880 [TBL] [Abstract][Full Text] [Related]
31. Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension. Sharpe ED; Henry CJ; Mundorf TK; Day DG; Stewart JA; Jenkins JN; Stewart WC Eye (Lond); 2005 Jan; 19(1):35-40. PubMed ID: 15094733 [TBL] [Abstract][Full Text] [Related]
32. Intraocular pressure-lowering efficacy of dorzolamide/timolol fixed combination in normal-tension glaucoma. Kim TW; Kim M; Lee EJ; Jeoung JW; Park KH J Glaucoma; 2014; 23(5):329-32. PubMed ID: 23377586 [TBL] [Abstract][Full Text] [Related]
33. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial. Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767 [TBL] [Abstract][Full Text] [Related]
38. Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension. Adkins JC; Balfour JA Drugs Aging; 1998 Mar; 12(3):225-41. PubMed ID: 9534022 [TBL] [Abstract][Full Text] [Related]
39. Short-term effects of brimonidine/timolol and dorzolamide/timolol on ocular perfusion pressure and blood flow in glaucoma. Siesky B; Harris A; Ehrlich R; Cantor L; Shoja MM; Rusia D; Hollander DA; Abrams L; Williams JM; Shoshani Y Adv Ther; 2012 Jan; 29(1):53-63. PubMed ID: 22246943 [TBL] [Abstract][Full Text] [Related]
40. Five-Year Pooled Data Analysis of the Ahmed Baerveldt Comparison Study and the Ahmed Versus Baerveldt Study. Christakis PG; Zhang D; Budenz DL; Barton K; Tsai JC; Ahmed IIK; Am J Ophthalmol; 2017 Apr; 176():118-126. PubMed ID: 28104418 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]